TELEMEDICINE USE DURING COVID-19 PANDEMIC : PROSPECTS AND CHALLENGES
Article Sidebar
Published:
Feb 23, 2021
Main Article Content
Abstract
Background: COVID-19 infection has become one of the current global health problems. The physical distancing and self-quarantine policies implemented to break the chain of disease complicate the interaction between doctors and patients. Telemedicine is a remote health service using electronic means for diagnosis, treatment and prevention of disease and injury, research and education, education of health service providers to improve health. The purpose of this literature review is to discuss the use of telemedicine during the current COVID-19 pandemic and the challenges of using it for its use in future medical practice.
Methods: Literature searches were performed using the search engines PubMed, Science Direct and Google Scholar. Literature search using a combination of keywords "clinical practice", "COVID-19", "telemedicine", "telehealth", "management" and "medical practice".
Discussion: The current COVID-19 crisis is causing an increasing burden on the health system. The use of telemedicine can apply the concept of "hospitality at home", namely medical care at home, where home care in some conditions is better than hospital treatment. However, the use of telemedicine is currently not getting enough attention from doctors and health policy makers so that the use of telemedicine cannot be maximized.
Conclusion: The use of telemedicine technology can help doctors in patient care interactions. Further research is needed to increase the effectiveness of telemedicine for better medical practice in the future.
Article Details
How to Cite
Adnan, M., & Pramaningtyas, M. (2021). TELEMEDICINE USE DURING COVID-19 PANDEMIC : PROSPECTS AND CHALLENGES. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, 8(3), 225-233. https://doi.org/10.53366/jimki.v8i3.247
Section
Article Review
References
1. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y, Ma X, Zhan F, Wang L, Hu T, Zhou H, Hu Z, Zhou W, Zhao L, Chen J, Meng Y, Wang J, Lin Y, Yuan J, Xie Z, Ma J, Liu WJ, Wang D, Xu W, Holmes EC, Gao GF, Wu G, Chen W, Shi W, Tan W. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet [Internet]. 2020;395(10224):565–74.
2. Raoult D, Zumla A, Locatelli F, Ippolito G, Kroemer G. Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses. Cell Stress [Internet]. 2020;4(4):66–75.
3. Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C, Agha M, Agha R. The Socio-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review. Int J Surg. 2020;
4. Scott BK, Hravnak M, Pamplin JC. Clinical Distancing and Mitigation of Coronavirus Disease 2019. Crit Care Explor. 2020;2(4):e0117.
5. Serper M, Volk ML. Current and Future Applications of Telemedicine to Optimize the Delivery of Care in Chronic Liver Disease. Clin Gastroenterol Hepatol. 2018;16(2):157–161.
6. Elkaddoum R, Haddad FG, Eid R, Kourie HR. Telemedicine for cancer patients during COVID-19 pandemic: between threats and opportunities. Futur Oncol. 2020;10–2.
7. Ghosh A, Gupta R, Misra A. Telemedicine for Diabetes Care in India during COVID19 Pandemic and National Lockdown Period: Guidelines for Physicians. Diabetes Metab Syndr Clin Res Rev. 2020;
8. Contreras CM, Metzger GA, Beane JD, Dedhia PH, Ejaz A, Pawlik TM. Telemedicine: Patient-Provider Clinical Engagement During the COVID-19 Pandemic and Beyond. J Gastrointest Surg. 2020;
9. Maleki M, Mousavi SM, Khosravizadeh O, Heidari M, Raadabadi M, Jahanpour M. Factors affecting use of telemedicine and telesurgery in cancer care (TTCC) among specialist physicians. Asian Pacific J Cancer Prev. 2018;19(11):3123–9.
10. Mann DM, Chen J, Chunara R, Testa PA, Nov O. COVID-19 transforms health care through telemedicine: evidence from the field. J Am Med Inform Assoc. 2020;
11. Ventura C, Gibson C, Collier GD. Emergency Medical Services resource capacity and competency amid COVID-19 in the United States: preliminary findings from a national survey. Heliyon [Internet]. 2020;6(5):e03900. Available from: https://doi.org/10.1016/j.heliyon.2020.e03900
12. Fong ZV, Qadan M, McKinney R, Griggs CL, Shah PC, Buyske J, Sachdeva AK, Callery MP, Altieri MS. Practical Implications of Novel Coronavirus COVID-19 on Hospital Operations, Board Certification, and Medical Education in Surgery in the USA. J Gastrointest Surg. 2020;
13. Liu Q, Luo D, Haase JE, Guo Q, Wang XQ, Liu S, Xia L, Liu Z, Yang J, Yang BX. The experiences of health-care providers during the COVID-19 crisis in China: a qualitative study. Lancet Glob Heal. 2020;(January).
14. Kretchy IA, Asiedu-Danso M, Kretchy J-P. Medication management and adherence during the COVID-19 pandemic: Perspectives and experiences from LMICs. Res Soc Adm Pharm. 2020;
15. Kang C, Yang S, Yuan J, Xu L, Zhao X, Yang J. Patients with chronic illness urgently need integrated physical and psychological care during the COVID-19 outbreak. Asian J Psychiatr. 2020;51(January).
16. Eccleston C, Blyth FM, Dear BF, Fisher EA, Keefe FJ, Lynch ME, Palermo TM, Reid MC, Williams AC d. C. Managing patients with chronic pain during the COVID-19 outbreak: considerations for the rapid introduction of remotely supported (eHealth) pain management services. Pain. 2020;161(5):889–93.
17. Bendelin N, Björkdahl P, Risell M, Nelson KZ, Gerdle B, Andersson G, Buhrman M. Patients’ experiences of internet-based Acceptance and commitment therapy for chronic pain: A qualitative study. BMC Musculoskelet Disord. 2020;21(1):1–12.
18. Hollander JE, Carr BG. Virtually Perfect? Telemedicine for Covid-19. N Engl J Med [Internet]. 2020; Available from: nejm.org
19. Zhang J, Wang X, Jia X, Li J, Chen G, Wei J, Gong Z, Zhou C, Yu H, Yu M, Lei H, Cheng F, Zhang B, Xu Y, Wang G, Dong W. Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020;
20. Richez C, Lazaro E, Lemoine M, Truchetet ME, Schaeverbeke T. Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases. Vol. 87, Joint Bone Spine. 2020. p. 187–9.
21. Baker J, Stanley A. Telemedicine Technology: a Review of Services, Equipment, and Other Aspects. Curr Allergy Asthma Rep. 2018;18(11).
22. Ohannessian R. Telemedicine: Potential applications in epidemic situations. Eur Res Telemed. 2015;4(3):95–8.
23. Portnoy J, Waller M, Elliott T. Telemedicine in the Era of COVID-19. J Allergy Clin Immunol Pract. 2020;8(5):1489–91.
24. Woolliscroft JO. Innovation in Response to the COVID-19 Pandemic Crisis. Acad Med. 2020;XX(X):1–3.
25. Ohannessian R, Duong TA, Odone A. Global Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action. JMIR Public Heal Surveill. 2020;6(2):e18810.
26. Negrini S, Kiekens C, Bernetti A, Capecci M, Ceravolo MG, Lavezzi S, Zampolini M, Boldrini P. Telemedicine from research to practice during the pandemic. “Instant paper from the field” on rehabilitation answers to the Covid-19 emergency. Eur J Phys Rehabil Med. 2020;
27. Silva CA, Queiroz LB, Fonseca C de B, Silva LEV da, Lourenço B, Marques HHS. Spotlight for healthy adolescents and adolescents with preexisting chronic diseases during the COVID-19 pandemic. Clinics (Sao Paulo). 2020;75:e1931.
28. Orozco-Beltran D, Sánchez-Molla M, Sanchez JJ, Mira JJ. Telemedicine in primary care for patients with Chronic conditions: The valcrònic quasi-experimental study. J Med Internet Res. 2017;19(12):1–12.
29. Hanlon P, Daines L, Campbell C, Mckinstry B, Weller D, Pinnock H. Telehealth interventions to support self-management of long-term conditions: A systematic metareview of diabetes, heart failure, asthma, chronic obstructive pulmonary disease, and cancer. J Med Internet Res. 2017;19(5).
30. Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, Liu XQ, Chen RC, Tang CL, Wang T, Ou CQ, Li L, Chen PY, Sang L, Wang W, Li JF, Li CC, Ou LM, Cheng B, Xiong S, Ni ZY, Xiang J, Hu Y, Liu L, Shan H, Lei CL, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Cheng LL, Ye F, Li SY, Zheng JP, Zhang NF, Zhong NS, He JX. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;(March 2020).
31. Shaker MS, Oppenheimer J, Grayson M, Stukus D, Hartog N, Hsieh EWY, Rider N, Dutmer CM, Vander Leek TK, Kim H, Chan ES, Mack D, Ellis AK, Lang D, Lieberman J, Fleischer D, Golden DBK, Wallace D, Portnoy J, Mosnaim G, Greenhawt M. COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic. J Allergy Clin Immunol Pract. 2020;8(5):1477-1488.e5.
32. Portnoy JM, Pandya A, Waller M, Elliott T. Telemedicine and emerging technologies for health care in allergy/immunology. J Allergy Clin Immunol [Internet]. 2020;145(2):445–54.
33. Correard F, Montaleytang M, Costa M, Astolfi M, Baumstarck K, Loubière S, Amichi K, Auquier P, Verger P, Villani P, Honore S, Daumas A. Impact of medication review via tele-expertise on unplanned hospitalizations at 3 months of nursing homes patients (TEM-EHPAD): Study protocol for a randomized controlled trial. BMC Geriatr. 2020;20(1):1–11.
34. Agarwal P, Kithulegoda N, Umpierre R, Pawlovich J, Pfeil JN, D’Avila OP, Goncalves M, Harzheim E, Ponka D. Telemedicine in the driver’s seat: new role for primary care access in Brazil and Canada. Can Fam Physician. 2020;66:104–11.
35. Omboni S. Telemedicine During The COVID-19 in Italy: A Missed Opportunity? Telemed e-Health. 2020;00(00):19–21.
36. Smith AC, Thomas E, Snoswell CL, Haydon H, Mehrotra A, Clemensen J, Caffery LJ. Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19). J Telemed Telecare. 2020;2019.
37. Combi C, Pozzani G, Pozzi G. Telemedicine for developing countries: A survey and some design issues. Appl Clin Inform. 2016;7(4):1025–50.
38. Iribarren SJ, Cato K, Falzon L, Stone PW. What is the economic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions. PLoS One. 2017;12(2):1–20.
39. Kim T, Zuckerman JE. Realizing the potential of telemedicine in global health. J Glob Health. 2019;9(2).
40. Ayatollahi H, Fatemeh S, Mostafa L. Clinicians ’ Knowledge and Perception of Telemedicine Technology. Perspect Heal Inf Manag [Internet]. 2015;12(1c):1–6.
41. El-Mahalli AA, El-Khafif SH, Al-Qahtani MF. Successes and challenges in the implementation and application of telemedicine in the eastern province of Saudi Arabia. Perspect Heal Inf Manag Assoc. 2012;9:1–27.
42. LeRouge C, Garfield MJ. Crossing the telemedicine chasm: Have the U.S. barriers to widespread adoption of telemedicine been significantly reduced? Int J Environ Res Public Health. 2013;10(12):6472–84.
43. Rho MJ, Choi I young, Lee J. Predictive factors of telemedicine service acceptance and behavioral intention of physicians. Int J Med Inform [Internet]. 2014;83(8):559–71.
44. Nittari G, Khuman R, Baldoni S, Pallotta G, Battineni G, Sirignano A, Amenta F, Ricci G. Telemedicine Practice: Review of the Current Ethical and Legal Challenges. Telemed e-Health. 2020;1–11.
45. Chaet D, Clearfield R, Sabin JE, Skimming K. Ethical practice in Telehealth and Telemedicine. J Gen Intern Med [Internet]. 2017;32(10):1136–40.
2. Raoult D, Zumla A, Locatelli F, Ippolito G, Kroemer G. Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses. Cell Stress [Internet]. 2020;4(4):66–75.
3. Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C, Agha M, Agha R. The Socio-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review. Int J Surg. 2020;
4. Scott BK, Hravnak M, Pamplin JC. Clinical Distancing and Mitigation of Coronavirus Disease 2019. Crit Care Explor. 2020;2(4):e0117.
5. Serper M, Volk ML. Current and Future Applications of Telemedicine to Optimize the Delivery of Care in Chronic Liver Disease. Clin Gastroenterol Hepatol. 2018;16(2):157–161.
6. Elkaddoum R, Haddad FG, Eid R, Kourie HR. Telemedicine for cancer patients during COVID-19 pandemic: between threats and opportunities. Futur Oncol. 2020;10–2.
7. Ghosh A, Gupta R, Misra A. Telemedicine for Diabetes Care in India during COVID19 Pandemic and National Lockdown Period: Guidelines for Physicians. Diabetes Metab Syndr Clin Res Rev. 2020;
8. Contreras CM, Metzger GA, Beane JD, Dedhia PH, Ejaz A, Pawlik TM. Telemedicine: Patient-Provider Clinical Engagement During the COVID-19 Pandemic and Beyond. J Gastrointest Surg. 2020;
9. Maleki M, Mousavi SM, Khosravizadeh O, Heidari M, Raadabadi M, Jahanpour M. Factors affecting use of telemedicine and telesurgery in cancer care (TTCC) among specialist physicians. Asian Pacific J Cancer Prev. 2018;19(11):3123–9.
10. Mann DM, Chen J, Chunara R, Testa PA, Nov O. COVID-19 transforms health care through telemedicine: evidence from the field. J Am Med Inform Assoc. 2020;
11. Ventura C, Gibson C, Collier GD. Emergency Medical Services resource capacity and competency amid COVID-19 in the United States: preliminary findings from a national survey. Heliyon [Internet]. 2020;6(5):e03900. Available from: https://doi.org/10.1016/j.heliyon.2020.e03900
12. Fong ZV, Qadan M, McKinney R, Griggs CL, Shah PC, Buyske J, Sachdeva AK, Callery MP, Altieri MS. Practical Implications of Novel Coronavirus COVID-19 on Hospital Operations, Board Certification, and Medical Education in Surgery in the USA. J Gastrointest Surg. 2020;
13. Liu Q, Luo D, Haase JE, Guo Q, Wang XQ, Liu S, Xia L, Liu Z, Yang J, Yang BX. The experiences of health-care providers during the COVID-19 crisis in China: a qualitative study. Lancet Glob Heal. 2020;(January).
14. Kretchy IA, Asiedu-Danso M, Kretchy J-P. Medication management and adherence during the COVID-19 pandemic: Perspectives and experiences from LMICs. Res Soc Adm Pharm. 2020;
15. Kang C, Yang S, Yuan J, Xu L, Zhao X, Yang J. Patients with chronic illness urgently need integrated physical and psychological care during the COVID-19 outbreak. Asian J Psychiatr. 2020;51(January).
16. Eccleston C, Blyth FM, Dear BF, Fisher EA, Keefe FJ, Lynch ME, Palermo TM, Reid MC, Williams AC d. C. Managing patients with chronic pain during the COVID-19 outbreak: considerations for the rapid introduction of remotely supported (eHealth) pain management services. Pain. 2020;161(5):889–93.
17. Bendelin N, Björkdahl P, Risell M, Nelson KZ, Gerdle B, Andersson G, Buhrman M. Patients’ experiences of internet-based Acceptance and commitment therapy for chronic pain: A qualitative study. BMC Musculoskelet Disord. 2020;21(1):1–12.
18. Hollander JE, Carr BG. Virtually Perfect? Telemedicine for Covid-19. N Engl J Med [Internet]. 2020; Available from: nejm.org
19. Zhang J, Wang X, Jia X, Li J, Chen G, Wei J, Gong Z, Zhou C, Yu H, Yu M, Lei H, Cheng F, Zhang B, Xu Y, Wang G, Dong W. Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020;
20. Richez C, Lazaro E, Lemoine M, Truchetet ME, Schaeverbeke T. Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases. Vol. 87, Joint Bone Spine. 2020. p. 187–9.
21. Baker J, Stanley A. Telemedicine Technology: a Review of Services, Equipment, and Other Aspects. Curr Allergy Asthma Rep. 2018;18(11).
22. Ohannessian R. Telemedicine: Potential applications in epidemic situations. Eur Res Telemed. 2015;4(3):95–8.
23. Portnoy J, Waller M, Elliott T. Telemedicine in the Era of COVID-19. J Allergy Clin Immunol Pract. 2020;8(5):1489–91.
24. Woolliscroft JO. Innovation in Response to the COVID-19 Pandemic Crisis. Acad Med. 2020;XX(X):1–3.
25. Ohannessian R, Duong TA, Odone A. Global Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action. JMIR Public Heal Surveill. 2020;6(2):e18810.
26. Negrini S, Kiekens C, Bernetti A, Capecci M, Ceravolo MG, Lavezzi S, Zampolini M, Boldrini P. Telemedicine from research to practice during the pandemic. “Instant paper from the field” on rehabilitation answers to the Covid-19 emergency. Eur J Phys Rehabil Med. 2020;
27. Silva CA, Queiroz LB, Fonseca C de B, Silva LEV da, Lourenço B, Marques HHS. Spotlight for healthy adolescents and adolescents with preexisting chronic diseases during the COVID-19 pandemic. Clinics (Sao Paulo). 2020;75:e1931.
28. Orozco-Beltran D, Sánchez-Molla M, Sanchez JJ, Mira JJ. Telemedicine in primary care for patients with Chronic conditions: The valcrònic quasi-experimental study. J Med Internet Res. 2017;19(12):1–12.
29. Hanlon P, Daines L, Campbell C, Mckinstry B, Weller D, Pinnock H. Telehealth interventions to support self-management of long-term conditions: A systematic metareview of diabetes, heart failure, asthma, chronic obstructive pulmonary disease, and cancer. J Med Internet Res. 2017;19(5).
30. Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, Liu XQ, Chen RC, Tang CL, Wang T, Ou CQ, Li L, Chen PY, Sang L, Wang W, Li JF, Li CC, Ou LM, Cheng B, Xiong S, Ni ZY, Xiang J, Hu Y, Liu L, Shan H, Lei CL, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Cheng LL, Ye F, Li SY, Zheng JP, Zhang NF, Zhong NS, He JX. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;(March 2020).
31. Shaker MS, Oppenheimer J, Grayson M, Stukus D, Hartog N, Hsieh EWY, Rider N, Dutmer CM, Vander Leek TK, Kim H, Chan ES, Mack D, Ellis AK, Lang D, Lieberman J, Fleischer D, Golden DBK, Wallace D, Portnoy J, Mosnaim G, Greenhawt M. COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic. J Allergy Clin Immunol Pract. 2020;8(5):1477-1488.e5.
32. Portnoy JM, Pandya A, Waller M, Elliott T. Telemedicine and emerging technologies for health care in allergy/immunology. J Allergy Clin Immunol [Internet]. 2020;145(2):445–54.
33. Correard F, Montaleytang M, Costa M, Astolfi M, Baumstarck K, Loubière S, Amichi K, Auquier P, Verger P, Villani P, Honore S, Daumas A. Impact of medication review via tele-expertise on unplanned hospitalizations at 3 months of nursing homes patients (TEM-EHPAD): Study protocol for a randomized controlled trial. BMC Geriatr. 2020;20(1):1–11.
34. Agarwal P, Kithulegoda N, Umpierre R, Pawlovich J, Pfeil JN, D’Avila OP, Goncalves M, Harzheim E, Ponka D. Telemedicine in the driver’s seat: new role for primary care access in Brazil and Canada. Can Fam Physician. 2020;66:104–11.
35. Omboni S. Telemedicine During The COVID-19 in Italy: A Missed Opportunity? Telemed e-Health. 2020;00(00):19–21.
36. Smith AC, Thomas E, Snoswell CL, Haydon H, Mehrotra A, Clemensen J, Caffery LJ. Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19). J Telemed Telecare. 2020;2019.
37. Combi C, Pozzani G, Pozzi G. Telemedicine for developing countries: A survey and some design issues. Appl Clin Inform. 2016;7(4):1025–50.
38. Iribarren SJ, Cato K, Falzon L, Stone PW. What is the economic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions. PLoS One. 2017;12(2):1–20.
39. Kim T, Zuckerman JE. Realizing the potential of telemedicine in global health. J Glob Health. 2019;9(2).
40. Ayatollahi H, Fatemeh S, Mostafa L. Clinicians ’ Knowledge and Perception of Telemedicine Technology. Perspect Heal Inf Manag [Internet]. 2015;12(1c):1–6.
41. El-Mahalli AA, El-Khafif SH, Al-Qahtani MF. Successes and challenges in the implementation and application of telemedicine in the eastern province of Saudi Arabia. Perspect Heal Inf Manag Assoc. 2012;9:1–27.
42. LeRouge C, Garfield MJ. Crossing the telemedicine chasm: Have the U.S. barriers to widespread adoption of telemedicine been significantly reduced? Int J Environ Res Public Health. 2013;10(12):6472–84.
43. Rho MJ, Choi I young, Lee J. Predictive factors of telemedicine service acceptance and behavioral intention of physicians. Int J Med Inform [Internet]. 2014;83(8):559–71.
44. Nittari G, Khuman R, Baldoni S, Pallotta G, Battineni G, Sirignano A, Amenta F, Ricci G. Telemedicine Practice: Review of the Current Ethical and Legal Challenges. Telemed e-Health. 2020;1–11.
45. Chaet D, Clearfield R, Sabin JE, Skimming K. Ethical practice in Telehealth and Telemedicine. J Gen Intern Med [Internet]. 2017;32(10):1136–40.